Surface modification with transferrin enabled the nanoplatform to target the overexpressed transferrin receptors in hepatocellular carcinoma (HCC) cells and facilitate tumor accumulation as well as intracellular DOX delivery. Here, TFRC is linked to hepatocellular carcinoma.